Press Releases Mountain Valley MD Holdings Inc.

Equities

MVMD

CA62430M1014

Market Closed - Canadian Securities Exchange Other stock markets 15:53:39 2024-05-10 EDT			5-day change	1st Jan Change
0.055 ^CAD	0.00%		0.00%	+37.50%

03-01	Mountain Valley MD Holdings Inc. Plans to Introduce Soluvec 1% Coated Fish Feed in Bangladesh by May of 2024	CI
03-01	Mountain Valley MD Holdings Inc. Provides Update on Agrarius Trial Results	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program	04-24	BU
Mountain Valley MD Announces Stock Option Grant	04-08	BU
Mountain Valley MD Provides Business Update, Appoints New CFO	03-01	BU
Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024	12-15	BU
Mountain Valley MD Announces Appointment of New CFO	23-09-07	BU
Mountain Valley MD Provides Business Update	23-08-10	BU
Mountain Valley MD Announces Publication of Soluvec™ Trial Data in Therapeutic Delivery	23-08-09	BU
Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection	23-05-08	GL
Mountain Valley MD Announces Stock Option Grant	23-03-06	GL
Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role	23-01-11	GL
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected	22-12-07	GL
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected	22-12-07	AQ
Mountain Valley MD Provides Business Update, Focus On Commercialization Phase	22-11-29	GL
Mountain Valley MD Provides Business Update, Focus On Commercialization Phase	22-11-29	AQ
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology	22-09-13	GL
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology	22-09-13	AQ
Mountain Valley MD : Q1 Financial Statements	22-08-25	PU
Mountain Valley MD : Q1 Management Discussion and Analysis	22-08-25	PU
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%	22-06-27	GL
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%	22-06-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mountain Valley MD Holdings Inc.

Equities

MVMD

CA62430M1014

Press Releases

Filters